Medical Lead Solid Tumors
AbbVie
Medical Lead Solid Tumors
AbbVie
Global biopharmaceutical company developing medicines
At AbbVie, we are committed to advancing innovative therapies that make a meaningful difference for people living with cancer. As Medical Lead Solid Tumors, you will play a pivotal role in shaping the medical strategy for our oncology portfolio, leading a team of medical professionals while serving as the key scientific partner across the organization and within the oncology community.
This is a leadership position, heading a team of 3, that combines people leadership, strategic thinking, scientific expertise, and external engagement. You'll work closely with cross-functional teams to ensure patients, healthcare professionals, and the wider oncology community benefit from the latest scientific advances.
What You'll Do
Lead the medical agenda in Solid Tumors
Build and develop a high-performing team
Partner with the oncology community
Drive evidence generation and scientific communication
Shape the future of oncology at AbbVie
As an employer, we value diversity and support people in developing their potential and strengths, realizing their ideas and seizing opportunities. The job advertisement is aimed equally at all people, regardless of age, skin color, religion, gender, sexual orientation or origin. For legal reasons, we are obliged to point out that the minimum salary for this position under the collective agreement is € 2,879.00 gross per month. However, our attractive salary packages are based on current market salaries and are therefore significantly higher than the stated minimum salary.
AbbVie setzt sich für Chancengleichheit ein und verpflichtet sich, mit Integrität zu arbeiten, Innovationen voranzutreiben, Leben zu verändern und unserer Gemeinschaft zu dienen. Chancengleichheit bei Arbeitgeber/Veteranen/Behinderten.
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Explore more opportunities at AbbVie